Contents of Forthcoming Issues · Themenvorschau
Cornelius Mensing, Hakan Karagöl, Gunnar Folprecht, Ferhat Kılınç, Anna Niwińska(The Maria Sklodowska-Curie National Research Institute of Oncology), Aneta Bałabas, Özgür Özyılkan, Naime Tokmak, Fatih Köse, Katharina Schuette(University Hospital Carl Gustav Carus), Wolfgang Abenhardt(Praxis für Hämatologie und Onkologie), Torsten Haferlach(Martin Luther Christian University), Matthias W. Beckmann(Universitätsklinikum Erlangen), Axel Hauschild(University Hospital Schleswig-Holstein), Peter Bojko, Fattaneh A. Tavassoli(Yale University), Elisabeth Livingstone(German Cancer Research Center), Dorota Nowakowska(The Maria Sklodowska-Curie National Research Institute of Oncology), Friedrich Overkamp, Hüseyin Mertsoylu, Atakan Sezer(Trakya University), Sernaz Uzunoğlu, Ursula Thyroff‐Friesinger, Hartmut Link(Medizinische Hochschule Hannover), İrfan Çiçin(Istinye University), Michalina Dąbrowska(The Maria Sklodowska-Curie National Research Institute of Oncology), Hakan Sakallı, K. Weigang-Köhler, Martin Kornacker(Roche (Switzerland)), Andrea Vetter, Suat Canbaz, Burkhard Otremba(Saarland University), Ufuk Usta, G. Huebner(Westpfalz Klinikum), E Kwiatkowska, E. Skasko, Thomas Schwarz(University of Lübeck), Ahmet Sezer(University of Pittsburgh Medical Center), Claus-Henning Koehne(Klinikum Oldenburg), Susanne Schnittger(Goethe University Frankfurt), David L. Wachter, Arndt Hartmann, Albrecht Kretzschmar(Roche (Switzerland)), Viktor Gruenwald(Medizinische Hochschule Hannover), Michael Stahl(Kliniken Essen-Mitte), Wolfgang Knauf(Krankenhaus Bethanien), Magdalena Piątkowska, George H. Sakorafas, Tadeusz Pieńkowski
Cited by 1
Related Papers
Improved Survival with Vemurafenib in Melanoma with BRAF V600E Mutation
|New England Journal of Medicine|2011|7.7k
Dabrafenib in BRAF-mutated metastatic melanoma: a multicentre, open-label, phase 3 randomised controlled trial
|The Lancet|2012|3k
Improved Overall Survival in Melanoma with Combined Dabrafenib and Trametinib
|New England Journal of Medicine|2014|2.7k